• Baba, M., Okamoto, M., Toyama, M., Sakakibara, N., Shimojima, M., Saijo, M., Niwa, T.,Yagi, Y., 2023. Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication. Antiviral Res, 210, 105479.

  • Boezio, B., Audouze, K., Ducrot, P.,Taboureau, O., 2017. Network-based Approaches in Pharmacology. Mol Inform, 36.

  • Chen, C.C., Qin, X.M., Du, G.H.,Zhou, Y.Z., 2019. The "compatible art" of effective components from traditional Chinese medicine: research on the compatibility and proportion of effective components. Acta Pharmaceutica Sinica, 54(5), 808-817.

  • Clevers, H., 2016. Modeling Development and Disease with Organoids. Cell, 165, 1586-1597.

  • Corro, C., Novellasdemunt, L.,Li, V.S.W., 2020. A brief history of organoids. Am J Physiol Cell Physiol, 319, C151-c165.

  • Davy, C.,Doorbar, J., 2007. G2/M cell cycle arrest in the life cycle of viruses. Virology, 368, 219-226.

  • Ding, J., Li, J., Zhang, Z., Du, Y., Liu, Y., Wang, P.,Du, H., 2023. Network pharmacology combined with metabolomics to explore the mechanism for Lonicerae Japonicae flos against respiratory syncytial virus. BMC Complement Med Ther, 23, 449.

  • Dutta, D., Heo, I.,Clevers, H., 2017. Disease Modeling in Stem Cell-Derived 3D Organoid Systems. Trends Mol Med, 23, 393-410.

  • Efferth, T., Li, P.C., Konkimalla, V.S.,Kaina, B., 2007. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med, 13, 353-361.

  • Feuer, R., Mena, I., Pagarigan, R., Slifka, M.K.,Whitton, J.L., 2002. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol, 76, 4430-4440.

  • Frazzi, R., 2021. BIRC3 and BIRC5: multi-faceted inhibitors in cancer. Cell Biosci, 11, 8.

  • Gearhart, T.L.,Bouchard, M.J., 2010. Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes. Virology, 407, 14-25.

  • Gu, X.L., Su, W.Q., Zhou, C.M., Fang, L.Z., Zhu, K., Ma, D.Q., Jiang, F.C., Li, Z.M., Li, D., Duan, S.H., Peng, Q.M., Wang, R., Jiang, Y., Han, H.J.,Yu, X.J., 2022. SFTSV infection in rodents and their ectoparasitic chiggers. PLoS Negl Trop Dis, 16, e0010698.

  • Guo, X., Zhang, L., Zhang, W., Chi, Y., Zeng, X., Li, X., Qi, X., Jin, Q., Zhang, X., Huang, M., Wang, H., Chen, Y., Bao, C., Hu, J., Liang, S., Bao, L., Wu, T., Zhou, M.,Jiao, Y., 2013. Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus. Clin Vaccine Immunol, 20, 1426-1432.

  • Ji, M., Hu, J., Zhang, D., Huang, B., Xu, S., Jiang, N., Chen, Y., Wang, Y., Wu, X.,Wu, Z., 2024. Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody. EMBO Mol Med, 16, 575-595.

  • Jung, S.I., Kim, Y.E., Yun, N.R., Kim, C.M., Kim, D.M., Han, M.A., Kim, U.J., Kim, S.E., Kim, J., Ryu, S.Y., et al., 2021. Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: A multicenter clinical cohort study. PLoS Negl Trop Dis, 15, e0009128.

  • Kang, S.Y., Yoo, J.R., Park, Y., Kim, S.H., Heo, S.T., Park, S.H., Kim, M., Kim, T.J., Oh, S., Lee, M.S., Kim, J.M., Cho, N.H., Lee, K.M.,Lee, K.H., 2023. Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-β. J Med Virol, 95, e28894.

  • Kim, K.H., Kim, J., Ko, M., Chun, J.Y., Kim, H., Kim, S., Min, J.Y., Park, W.B., Oh, M.D.,Chung, J., 2019. An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus. PLoS Pathog, 15, e1007375.

  • Kuchta, K., Cameron, S., Lee, M., Cai, S.Q.,Shoyama, Y., 2022. Which East Asian herbal medicines can decrease viral infections? Phytochem Rev, 21, 219-237.

  • Li, D.,Saldanha, F.J.D., 2008. Clinical Analysis of Acupuncture Combined with Chinese Patent Medicine in the Treatment of Dengue Fever. Practical Traditional Chinese Medicine, 24(09), 553-554.

  • Li, H., Zhang, L.K., Li, S.F., Zhang, S.F., Wan, W.W., Zhang, Y.L., Xin, Q.L., Dai, K., Hu, Y.Y., Wang, Z.B., et al., 2019. Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res, 29, 739-753.

  • Li, Q., Jia, C., Wu, H., Liao, Y., Yang, K., Li, S., Zhang, J., Wang, J., Li, G., Guan, F., Leung, E., Yuan, Z., Hua, Q.,Pan, R.Y., 2022. Nao Tan Qing ameliorates Alzheimer's disease-like pathology by regulating glycolipid metabolism and neuroinflammation: A network pharmacology analysis and biological validation. Pharmacol Res, 185, 106489.

  • Lim, S.,Kaldis, P., 2013. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development, 140, 3079-3093.

  • Liu, S., Liu, H., Kang, J., Xu, L., Zhang, K., Li, X., Hou, W., Wang, Z.,Wang, T., 2020. The Severe Fever with Thrombocytopenia Syndrome Virus NSs Protein Interacts with CDK1 To Induce G(2) Cell Cycle Arrest and Positively Regulate Viral Replication. J Virol, 94, e01575-19. .

  • Lu, Q.B., Zhang, S.Y., Cui, N., Hu, J.G., Fan, Y.D., Guo, C.T., Qin, S.L., Yang, Z.D., Wang, L.Y., Wang, H.Y., Zhang, X.A., Liu, W.,Cao, W.C., 2015. Common adverse events associated with ribavirin therapy for Severe Fever with Thrombocytopenia Syndrome. Antiviral Res, 119, 19-22.

  • Luo, N., Li, M., Xu, M., Shi, C., Shi, X., Ni, R., Chen, Y., Zheng, L., Tu, Y., Hu, D., Yu, C., Li, Q.,Lu, Y., 2023. Research Progress of Fever with Thrombocytopenia Syndrome. Intensive Care Res, 10.1007/s44231-023-00035-6, 1-10.

  • Muhammad, J., Khan, A., Ali, A., Fang, L., Yanjing, W., Xu, Q.,Wei, D.Q., 2018. Network Pharmacology: Exploring the Resources and Methodologies. Curr Top Med Chem, 18, 949-964.

  • Sakaguchi, K., Koga, Y., Yagi, T., Nakahara, T., Todani, M., Fujita, M.,Tsuruta, R., 2019. Severe Fever with Thrombocytopenia Syndrome Complicated with Pseudomembranous Aspergillus Tracheobronchitis in a Patient without Apparent Risk Factors for Invasive Aspergillosis. Intern Med, 58, 3589-3592.

  • Sehgal, A., Mehta, S., Sahay, K., Martynova, E., Rizvanov, A., Baranwal, M., Chandy, S., Khaiboullina, S., Kabwe, E.,Davidyuk, Y., 2023. Hemorrhagic Fever with Renal Syndrome in Asia: History, Pathogenesis, Diagnosis, Treatment, and Prevention. Viruses, 15, 561.

  • Seo, J.W., Kim, D., Yun, N.,Kim, D.M., 2021. Clinical Update of Severe Fever with Thrombocytopenia Syndrome. Viruses, 13, 1213.

  • Singh, S., Numan, A., Sharma, D., Shukla, R., Alexander, A., Jain, G.K., Ahmad, F.J.,Kesharwani, P., 2022. Epidemiology, virology and clinical aspects of hantavirus infections: an overview. Int J Environ Health Res, 32, 1815-1826.

  • Su, W.Y., Lo, H.H., Wen, Y.L., Lu, J.W., Yen, I.C., Ho, Y.J.,Kao, L.T., 2025. Assessing Traditional Chinese Medicines for Anti-Dengue Using a National Health Insurance Research Database and Bioassays. Food Sci Nutr, 13, e70009.

  • Sun, Y., Jin, C., Zhan, F., Wang, X., Liang, M., Zhang, Q., Ding, S., Guan, X., Huo, X., Li, C., Qu, J., Wang, Q., Zhang, S., Zhang, Y., Wang, S., Xu, A., Bi, Z.,Li, D., 2012. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis, 206, 1085-1094.

  • Suo, T., Wang, H.,Li, Z., 2016. Application of proteomics in research on traditional Chinese medicine. Expert Rev Proteomics, 13, 873-881.

  • Tani, H., Fukuma, A., Fukushi, S., Taniguchi, S., Yoshikawa, T., Iwata-Yoshikawa, N., Sato, Y., Suzuki, T., Nagata, N., Hasegawa, H., Kawai, Y., Uda, A., Morikawa, S., Shimojima, M., Watanabe, H.,Saijo, M., 2016. Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus. mSphere, 1, e00061.-15.

  • Tani, H., Komeno, T., Fukuma, A., Fukushi, S., Taniguchi, S., Shimojima, M., Uda, A., Morikawa, S., Nakajima, N., Furuta, Y.,Saijo, M., 2018. Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration. PLoS One, 13, e0206416.

  • Verbeeck, R.K., 2008. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol, 64, 1147-1161.

  • Wang, X., Wang, Z.Y., Zheng, J.H.,Li, S., 2021. TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med, 19, 1-11.

  • Wu, Y., Xiong, J., Zhao, X., Mei, Y.,Jiang, H., 2024. Conducted a clinical study on the treatment of acute stage bronchial asthma in children with damp heat syndrome using Ganlu Disinfectant Pill combined with acupoint application. 45(05), 51-53.

  • Yan, C., Niu, Y.,Wang, X., 2022. Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV. Front Immunol, 13, 1008653.

  • Yang, M., Sheng, Q., Ge, S., Song, X., Dong, J., Guo, C.,Liao, L., 2023. Mutations and clinical characteristics of dRTA caused by SLC4A1 mutations: Analysis based on published patients. Front Pediatr, 11, 1077120.

  • Yoo, J.R., Kim, T.J., Heo, S.T., Hwang, K.A., Oh, H., Ha, T., Ko, H.K., Baek, S., Kim, J.E., Kim, J.H., Lee, J., Kang, M.J., Yoo, M.S., Kim, J.M., Lee, K.M.,Lee, K.H., 2021. IL-6 and IL-10 Levels, Rather Than Viral Load and Neutralizing Antibody Titers, Determine the Fate of Patients With Severe Fever With Thrombocytopenia Syndrome Virus Infection in South Korea. Front Immunol, 12, 711847.

  • Zhang, C., Quan, Y., Yang, L., Bai, Y.,Yang, Y., 2022. 6-Methoxyflavone induces S-phase arrest through the CCNA2/CDK2/p21CIP1 signaling pathway in HeLa cells. Bioengineered, 13, 7277-7292.

  • Zhao, L., Zhang, H., Li, N., Chen, J., Xu, H., Wang, Y.,Liang, Q., 2023. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol, 309, 116306.